Evidence map›Paper›PMID 33801954›Full record

ArticleCancers2021

Neo-Fs Index: A Novel Immunohistochemical Biomarker Panel Predicts Survival and Response to Anti-Angiogenetic Agents in Clear Cell Renal Cell Carcinoma.

Jisup Kim, Jee-Young Park, Su-Jin Shin, Beom Jin Lim, Heounjeong Go

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of the mScientific reports · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jisup KimDepartment of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.ORCID 0000-0002-0742-5517
Jee-Young ParkDepartment of Pathology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu 41944, Korea.
Su-Jin ShinDepartment of Pathology, Yonsei University College of Medicine, Seoul 03722, Korea.ORCID 0000-0001-9114-8438
Beom Jin LimDepartment of Pathology, Yonsei University College of Medicine, Seoul 03722, Korea.
Heounjeong GoDepartment of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.ORCID 0000-0003-0412-8709
Ulsan College · KRYonsei University · KRKyungpook National University Medical Center · KR

Funding

Asan Institute for Life Sciences, Asan Medical Center 2020IP800National Research Foundation of Korea NRF-2018R1C1B6007360
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-angiogenic agent responseclear cell renal cell carcinomaframeshift insertion and deletionimmunohistochemical biomarkerprognosis

Identifiers

PMID33801954
PMCPMC8000111
OpenAlexW3133917672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.